IL134958A0 - Serotonin containing formulation for oral administration and method of use - Google Patents

Serotonin containing formulation for oral administration and method of use

Info

Publication number
IL134958A0
IL134958A0 IL13495898A IL13495898A IL134958A0 IL 134958 A0 IL134958 A0 IL 134958A0 IL 13495898 A IL13495898 A IL 13495898A IL 13495898 A IL13495898 A IL 13495898A IL 134958 A0 IL134958 A0 IL 134958A0
Authority
IL
Israel
Prior art keywords
oral administration
containing formulation
serotonin containing
serotonin
formulation
Prior art date
Application number
IL13495898A
Other languages
English (en)
Original Assignee
Serotoen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26730230&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL134958(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Serotoen Inc filed Critical Serotoen Inc
Publication of IL134958A0 publication Critical patent/IL134958A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL13495898A 1997-10-08 1998-10-06 Serotonin containing formulation for oral administration and method of use IL134958A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6133697P 1997-10-08 1997-10-08
US09/052,135 US6017946A (en) 1997-10-08 1998-03-31 Serotonin containing formulation for oral administration and method of use
PCT/US1998/020481 WO1999017612A1 (fr) 1997-10-08 1998-10-06 Procede d'elaboration d'une preparation orale contenant de la serotonine, et methodes d'utilisation associees

Publications (1)

Publication Number Publication Date
IL134958A0 true IL134958A0 (en) 2001-05-20

Family

ID=26730230

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13495898A IL134958A0 (en) 1997-10-08 1998-10-06 Serotonin containing formulation for oral administration and method of use

Country Status (12)

Country Link
US (1) US6017946A (fr)
EP (1) EP1021087A4 (fr)
JP (1) JP2001518481A (fr)
KR (1) KR20010024462A (fr)
CN (1) CN1279582A (fr)
AU (1) AU9780598A (fr)
BR (1) BR9813856A (fr)
CA (1) CA2305190A1 (fr)
IL (1) IL134958A0 (fr)
MX (1) MXPA00003385A (fr)
NO (1) NO20001717L (fr)
WO (1) WO1999017612A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1320776B1 (it) * 2000-08-07 2003-12-10 Giampiero Valletta Composizione farmaceutica a base di un'associazione vitaminica per laterapia delle cefalee primarie
JP2003119139A (ja) * 2001-10-12 2003-04-23 Ss Pharmaceut Co Ltd 疲労回復医薬組成物
US9408405B2 (en) * 2003-10-03 2016-08-09 Veijlen N.V. Use of compounds that are able to increase the serum IGF-1 level for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced IGF-1 serum level in humans and animals
SI1667678T1 (sl) 2003-10-03 2009-12-31 Veijlen N V Sestavek za ĺ˝ivalsko hrano
JP4147280B2 (ja) * 2003-12-16 2008-09-10 独立行政法人理化学研究所 グルタミン含有エネルギー付加型アミノ酸組成物又はアミノ酸溶液
US8133258B2 (en) * 2006-08-03 2012-03-13 Arthrocare Corporation Method and apparatus for attaching connective tissues to bone using a knotless suture anchoring device
EP1925214A1 (fr) * 2006-11-24 2008-05-28 DSMIP Assets B.V. Composition diététique ou pharmaceutique contenant cu carnosol et/ou du rosmanol
WO2019238998A1 (fr) * 2018-06-13 2019-12-19 Servicio Andaluz De Salud Utilisation d'antioxydants pour le traitement de la dépression chez des patients adultes
TR2021005231A1 (tr) * 2018-09-27 2022-02-21 Univ Yildiz Teknik Sperm hizini arttiran serotoni̇n etken maddesi̇ i̇çeren bi̇leşi̇m
KR20210113716A (ko) 2020-03-09 2021-09-17 (주)아모레퍼시픽 성분 함량이 변화된 녹차 추출물을 포함하는 여성호르몬 조절 이상 질환 또는 증상의 예방, 완화, 개선 또는 치료용 조성물
KR102192573B1 (ko) 2020-08-12 2020-12-18 문종진 생리통 및 피부 트러블의 예방 및 개선용 조성물
IL301656A (en) * 2020-10-12 2023-05-01 Goodcap Pharmaceuticals Ltd Preparations to reduce inflammation to improve or maintain mental or physical health

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883554A (en) * 1970-10-26 1975-05-13 Kyowa Hakko Kogyo Kk Process for preparing 5-hydroxy-tryptophan and its derivatives
DE3104815C2 (de) * 1980-02-13 1983-07-07 Japan Atomic Energy Research Institute, Tokyo Verfahren zur Herstellung eines Verbundstoffs mit Langzeit-Freigabe
US4596807A (en) * 1985-03-26 1986-06-24 Serotonin Industries Of Charleston Method and compositions for controlling pain, depression and sedation
DE3601472A1 (de) * 1986-01-20 1987-07-23 Fresenius Ag Verwendung von umsetzungsprodukten von reduzierenden zuckern und serotonin oder serotonin-precursoren zur behandlung cerebraler stoerungen
US5032578A (en) * 1990-09-17 1991-07-16 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine
US5653987A (en) * 1995-05-16 1997-08-05 Modi; Pankaj Liquid formulations for proteinic pharmaceuticals

Also Published As

Publication number Publication date
KR20010024462A (ko) 2001-03-26
EP1021087A1 (fr) 2000-07-26
AU9780598A (en) 1999-04-27
WO1999017612A1 (fr) 1999-04-15
EP1021087A4 (fr) 2001-08-22
NO20001717D0 (no) 2000-04-03
US6017946A (en) 2000-01-25
MXPA00003385A (es) 2002-11-20
BR9813856A (pt) 2000-09-19
CA2305190A1 (fr) 1999-04-15
JP2001518481A (ja) 2001-10-16
CN1279582A (zh) 2001-01-10
NO20001717L (no) 2000-04-03

Similar Documents

Publication Publication Date Title
EG24044A (en) pharmaceutical formulation of omeprazole
HUP0203374A3 (en) Sold oral pharmaceutical composition and process for its preparation
PL330814A1 (en) Compounds for and methods of delivering pharmaceutical preparations and their application
ZA982609B (en) Pharmaceutical composition for the oral administration of an n-piperidinopyrazole-e-carboxamide derivative its salts and their solvates
HUP9903734A3 (en) Controlled-release pharmaceutical formulations for oral administration and method for preparing this
PL341566A1 (en) Oral composition of yttraconasole preparation and method of obtaining same
HUP9900413A3 (en) Use of coralyne derivatives, new coralyne derivatives and use thereof, pharmaceutical compositions containing these new coralyne derivatives
HUP0101017A3 (en) Compositions and methods for systemic delivery of oral vaccines and therapeutic agents
HUP0300836A3 (en) Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
CZ20011652A3 (cs) Farmaceutický přípravek zahrnující moxifloxacin, způsob výroby a použití tohoto přípravku
IL126271A0 (en) 2-Arylpyrazolisoquinoline and cinnolinone derivatives methods for their preparation and pharmaceutical formulations containing them
HUP9900751A3 (en) Stable pharmaceutical forms of administration containing parathormone
ZA9410056B (en) Indoline derivatives method of preparation and use
HU9700039D0 (en) New oral pharmaceutical formulation containing magnesium salt of omeprazole
PL341230A1 (en) Solid dosage forms of ribavirin for oral administration and method of obtaining them
GB9710800D0 (en) Pharmaceutical composition and method of preparing it
IL113431A0 (en) Naphthalene derivatives method of preparation and use and pharmaceutical compositions containing them
IL134958A0 (en) Serotonin containing formulation for oral administration and method of use
ZA9670B (en) Composition and methods for transdermal delivery of acid-lability drugs
IL115125A0 (en) Pharmaceutical formulations comprising derivatives of clavulanic acid
AU8015398A (en) Pharmaceutical formulations containing colostrum and the use of colostrum for the treatment of affections of the oral cavity
AU3937693A (en) Methods and compositions for oral delivery of therapeutic agents
HUP0001773A3 (en) Substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them
ZA9811795B (en) New n-phenylamide and n-pyridyamide derivatives methods of preparing them and pharmaceutical compositions containing them